Active Ingredient: DEFERASIROX
Proprietary Name: DEFERASIROX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 180MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211383
Product Number: 003
Approval Date: Jun 15, 2020
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information